Literature DB >> 18201699

The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma.

Ingrid Revet1, Gerda Huizenga, Alvin Chan, Jan Koster, Richard Volckmann, Peter van Sluis, Ingrid Øra, Rogier Versteeg, Dirk Geerts.   

Abstract

Neuroblastoma is an embryonal tumour of the peripheral sympathetic nervous system (SNS). One of the master regulator genes for peripheral SNS differentiation, the homeobox transcription factor PHOX2B, is mutated in familiar and sporadic neuroblastomas. Here we report that inducible expression of PHOX2B in the neuroblastoma cell line SJNB-8 down-regulates MSX1, a homeobox gene important for embryonic neural crest development. Inducible expression of MSX1 in SJNB-8 caused inhibition of both cell proliferation and colony formation in soft agar. Affymetrix micro-array and Northern blot analysis demonstrated that MSX1 strongly up-regulated the Delta-Notch pathway genes DLK1, NOTCH3, and HEY1. In addition, the proneural gene NEUROD1 was down-regulated. Western blot analysis showed that MSX1 induction caused cleavage of the NOTCH3 protein to its activated form, further confirming activation of the Delta-Notch pathway. These experiments describe for the first time regulation of the Delta-Notch pathway by MSX1, and connect these genes to the PHOX2B oncogene, indicative of a role in neuroblastoma biology. Affymetrix micro-array analysis of a neuroblastic tumour series consisting of neuroblastomas and the more benign ganglioneuromas showed that MSX1, NOTCH3 and HEY1 are more highly expressed in ganglioneuromas. This suggests a block in differentiation of these tumours at distinct developmental stages or lineages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201699     DOI: 10.1016/j.yexcr.2007.12.008

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  41 in total

Review 1.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients.

Authors:  Andrea Bandino; Dirk Geerts; Jan Koster; André S Bachmann
Journal:  Cell Oncol (Dordr)       Date:  2014-10-15       Impact factor: 6.730

3.  PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma.

Authors:  Joanna E Gawecka; Dirk Geerts; Jan Koster; Maisel J Caliva; Florian J Sulzmaier; John Opoku-Ansah; Randal K Wada; André S Bachmann; Joe W Ramos
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

4.  Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection.

Authors:  Jessy Hasna; Frédéric Hague; Lise Rodat-Despoix; Dirk Geerts; Catherine Leroy; David Tulasne; Halima Ouadid-Ahidouch; Philippe Kischel
Journal:  Cell Death Differ       Date:  2018-01-11       Impact factor: 15.828

5.  Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells.

Authors:  Micaela Pannella; Cristiana Caliceti; Francesca Fortini; Giorgio Aquila; Francesco Vieceli Dalla Sega; Antonio Pannuti; Cinzia Fortini; Marco Bruno Morelli; Alessandro Fucili; Gloria Francolini; Rebecca Voltan; Paola Secchiero; Giovanni Dinelli; Emanuela Leoncini; Manuela Ferracin; Silvana Hrelia; Lucio Miele; Paola Rizzo
Journal:  J Cell Physiol       Date:  2016-04-04       Impact factor: 6.384

6.  Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.

Authors:  Ingo Lange; Dirk Geerts; David J Feith; Gabor Mocz; Jan Koster; André S Bachmann
Journal:  J Mol Biol       Date:  2013-10-01       Impact factor: 5.469

7.  The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.

Authors:  Dirk Geerts; Jan Koster; David Albert; Dana-Lynn T Koomoa; David J Feith; Anthony E Pegg; Richard Volckmann; Huib Caron; Rogier Versteeg; André S Bachmann
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

8.  PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.

Authors:  Tiziana Bachetti; Daniela Di Paolo; Simona Di Lascio; Valentina Mirisola; Chiara Brignole; Marta Bellotti; Irene Caffa; Chiara Ferraris; Michele Fiore; Diego Fornasari; Roberto Chiarle; Silvia Borghini; Ulrich Pfeffer; Mirco Ponzoni; Isabella Ceccherini; Patrizia Perri
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

9.  DNA methylation dynamics during intestinal stem cell differentiation reveals enhancers driving gene expression in the villus.

Authors:  Lucas T J Kaaij; Marc van de Wetering; Fang Fang; Benjamin Decato; Antoine Molaro; Harmen J G van de Werken; Johan H van Es; Jurian Schuijers; Elzo de Wit; Wouter de Laat; Gregory J Hannon; Hans C Clevers; Andrew D Smith; René F Ketting
Journal:  Genome Biol       Date:  2013-05-28       Impact factor: 13.583

10.  NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells.

Authors:  Stefan Nagel; Letizia Venturini; Grzegorz K Przybylski; Piotr Grabarczyk; Corinna Meyer; Maren Kaufmann; Karin Battmer; Christian A Schmidt; Hans G Drexler; Michaela Scherr; Roderick Af Macleod
Journal:  BMC Cancer       Date:  2009-10-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.